Skip to content

Translational research on rare earth-modified antibiotic bone cement promoting diabetic foot ulcer healing by regulating macrophage polarization via the PI3K/AKT/mTOR pathway

Translational research on rare earth-modified antibiotic bone cement promoting diabetic foot ulcer healing by regulating macrophage polarization via the PI3K/AKT/mTOR pathway

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600130542
Enrollment
Unknown
Registered
2026-08-21
Start date
2026-08-21
Completion date
Unknown
Last updated
2026-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes foot

Interventions

Sponsors

The First Affiliated Hospital of the Baotou Medical College of Inner Mongolia University of Science and Technology
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1.Age range: 18-80 years old, gender not limited; 2.Conform to the diagnostic criteria for type 2 diabetes (WHO, 1999); 3.Wagner grade 2-4 diabetes foot ulcer; 4.Sign informed consent form;

Exclusion criteria

Exclusion criteria: 1.Severe liver, liver, and kidney dysfunction (ALT/AST>3 times the upper limit of normal values, Cr>2 times the upper limit of normal values); 2.Severe ischemia of lower limb arteries (ABI<0.6); 3.Combining immune system diseases or tumors; 4.Allergic to PMMA or vancomycin; 5.Pregnant or lactating women.

Design outcomes

Primary

MeasureTime frame
Wound healing speed;Macrophage infiltration (CD68), M2 macrophage marker (CD206), PI3K/AKT pathway activity markers (p-AKT, Ser473);M1 related genes: iNOS, TNF - a, IL-1 ß; M2 related genes: Arg-1, CD206, IL-10;

Secondary

MeasureTime frame
Wagner ulcer grading;Baseline Data;

Countries

China

Contacts

Public ContactLian Jianqiang

The First Affiliated Hospital of the Baotou Medical College of Inner Mongolia University of Science and Technology

lian200655@163.com+86 472 217 8716

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026